Jacob Nowicki

Suggest Changes
Learn More
OBJECTIVE This randomized, 2-year, double-blind, placebo-controlled, crossover study evaluated cladribine for relapsing forms of multiple sclerosis. DESIGN PATIENTS (n = 84) received seven 5-day(More)